This week, we have conversations with Marc Hedrick, CEO of Cerenome, about a combined approach to tackling central nervous system (CNS) cancers, and Shaun Holt, CEO of Alveo Technologies, about the potential for animal diseases to jump to humans, and what we can do about it.
Times:
03:27 Cerenome
28:27 Alveo Technologies
Cerenome
Cerenome, formerly known as Plus Therapeutics, is a central nervous system (CNS) oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers.
The company’s CNSide Diagnostics platform supports the detection, molecular characterisation, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing.
Its lead therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and paediatric brain cancers.
The data and artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.
Alveo Technologies
Alveo Technologies, Inc. is a global molecular diagnostics company working on rapid, point-of-need molecular diagnostics for early disease detection.
It has developed a portable, cloud-connected platform that brings laboratory-quality pathogen detection directly to the Point of Need for farmers, veterinarians and public health officials. By decentralising molecular diagnostics, Alveo enables rapid detection and decision-making to help protect animal and human health, food security and supply chain resiliency.
The company recently announced a strategic partnership with AgriNerds Inc, which has developed the Waterfowl Alert Network, a first-of-its-kind dynamic surveillance and awareness programme that predicts historic and daily waterfowl activity around the nation’s poultry and livestock farms.
The partnership will pair Alveo’s molecular diagnostic with AgriNerds’ Waterfowl Alert Network, a proprietary system that uses a combination of satellite imagery, weather radar, and telemetry to create daily farm-level HPAI risk scores based on remote sensing and HPAI surveillance data.
To get in touch with guest suggestions, or to sponsor or advertise on the podcast, please email jim@deeptechdigest.com